Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate.

Tokgoz H, Aydin K, Oran B, Kiyici A.

Childs Nerv Syst. 2012 Jul;28(7):1049-53. doi: 10.1007/s00381-012-1788-7. Epub 2012 May 30.

PMID:
22645062
2.

Importance of accurate measurement of carotid intima-media thickness for evaluating epileptic children treated with valproate.

Ozkan F, Inci MF, Demir CF.

Childs Nerv Syst. 2013 Mar;29(3):355-6. doi: 10.1007/s00381-013-2028-5. Epub 2013 Jan 15. No abstract available.

PMID:
23319106
3.

Reply from the authors of the article entitled "Importance of accurate measurement of carotid intima media thickness for evaluating epileptic children treated with valproate".

Tokgoz H, Oran B, Aydin K.

Childs Nerv Syst. 2013 Mar;29(3):357. doi: 10.1007/s00381-013-2029-4. Epub 2013 Jan 15. No abstract available.

PMID:
23319107
4.

Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate.

Cansu A, Serdaroglu A, Camurdan O, Hırfanoğlu T, Cinaz P.

Horm Res Paediatr. 2011;76(1):65-71. doi: 10.1159/000327367. Epub 2011 Jun 10.

PMID:
21659721
5.

Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate.

Aydin K, Serdaroglu A, Okuyaz C, Bideci A, Gucuyener K.

J Child Neurol. 2005 Oct;20(10):848-51.

PMID:
16417885
6.

The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-Y levels of prepubertal children with epilepsy.

Ozcelik AA, Serdaroglu A, Bideci A, Arhan E, Soysal Ş, Demir E, Gücüyener K.

Pediatr Neurol. 2014 Aug;51(2):220-4. doi: 10.1016/j.pediatrneurol.2014.05.001. Epub 2014 May 10.

PMID:
25079570
7.

The role of ghrelin in weight gain and growth in epileptic children using valproate.

Gungor S, Yücel G, Akinci A, Tabel Y, Ozerol IH, Yologlu S.

J Child Neurol. 2007 Dec;22(12):1384-8. doi: 10.1177/0883073807307096.

PMID:
18174556
8.

The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy.

Sonmez FM, Zaman D, Aksoy A, Deger O, Aliyazicioglu R, Karaguzel G, Fazlioglu K.

Seizure. 2013 Dec;22(10):856-61. doi: 10.1016/j.seizure.2013.07.007. Epub 2013 Aug 9.

9.

Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment.

Okuyaz C, Kursel O, Komur M, Tamer L.

Pediatr Neurol. 2012 Dec;47(6):423-6. doi: 10.1016/j.pediatrneurol.2012.08.003.

PMID:
23127262
10.

Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving oxcarbazepine.

Cansu A, Serdaroglu A, Cinaz P.

Eur J Paediatr Neurol. 2011 Nov;15(6):527-31. doi: 10.1016/j.ejpn.2011.05.004. Epub 2011 Jun 23.

PMID:
21703891
11.

The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.

Çiçek NP, Kamaşak T, Serin M, Okten A, Alver A, Cansu A.

Seizure. 2018 Apr 11;58:90-95. doi: 10.1016/j.seizure.2018.03.013. [Epub ahead of print]

PMID:
29679911
12.

States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.

Hamed SA, Fida NM, Hamed EA.

Eur J Paediatr Neurol. 2009 May;13(3):261-8. doi: 10.1016/j.ejpn.2008.05.005. Epub 2008 Jun 30.

PMID:
18586538
13.

Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid.

Greco R, Latini G, Chiarelli F, Iannetti P, Verrotti A.

Neurology. 2005 Dec 13;65(11):1808-9.

PMID:
16344528
14.

Serum insulin and leptin levels in valproate-associated obesity.

Pylvänen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isojärvi JI.

Epilepsia. 2002 May;43(5):514-7.

15.

Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study.

Sidhu HS, Srinivas R, Sadhotra A.

Seizure. 2017 May;48:15-21. doi: 10.1016/j.seizure.2017.03.007. Epub 2017 Mar 22.

PMID:
28365440
16.

Circulating levels of allopregnanolone, a neuroactive steroid, and leptin during treatment with valproic acid in children with epilepsy.

Grosso S, Luisi S, Mostardini R, Matera M, Barlocco EG, Casarosa E, Balestri P, Petraglia F.

Neuroendocrinology. 2011;93(3):159-64. doi: 10.1159/000321664. Epub 2010 Oct 27.

PMID:
20980729
17.

Adiponectin and visfatin concentrations in children treated with valproic acid.

Rauchenzauner M, Haberlandt E, Scholl-Bürgi S, Ernst B, Hoppichler F, Karall D, Ebenbichler CF, Rostasy K, Luef G.

Epilepsia. 2008 Feb;49(2):353-7. Epub 2007 Dec 6.

18.

Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy.

Luef G, Abraham I, Hoppichler F, Trinka E, Unterberger I, Bauer G, Lechleitner M.

Metabolism. 2002 Oct;51(10):1274-8.

PMID:
12370846
19.

[Relationships between serum ghrelin and lipid profile and serum leptin, adiponectin, and insulin among children in Beijing, China].

Du S, Hu X, Liu A, Zhang Q, Pan H, Ma G.

Wei Sheng Yan Jiu. 2013 Mar;42(2):252-6, 262. Chinese.

PMID:
23654102
20.

Insulin resistance in patients on valproic acid: relation to adiponectin.

Aly RH, Amr NH, Saad WE, Megahed AA.

Acta Neurol Scand. 2015 Mar;131(3):169-75. doi: 10.1111/ane.12313. Epub 2014 Oct 7.

PMID:
25286962

Supplemental Content

Support Center